Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on H acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel Pd-catalyzed method offers high yield and enantioselectivity for pharmaceutical intermediates manufacturing supply chain and significant cost reduction benefits for global buyers seeking reliability.
Patent CN111848322B details a novel chiral phosphoric acid catalyzed resolution for axially chiral oxindole-substituted styrenes, offering high enantioselectivity and mild conditions for pharmaceutical intermediate manufacturing.
Novel synthesis method patent CN116199614B offers high enantioselectivity and cost reduction in pharmaceutical intermediates manufacturing for global supply chains.
Novel 3-step synthesis route from 1-fluorocyclopropanecarboxylic acid. Achieves >60% total yield, avoids fluoromethylation byproducts. Ideal for GPR40 agonist intermediates.
Patent CN111848322B details a novel chiral phosphoric acid resolution method for axially chiral oxindole-substituted styrenes, offering high enantioselectivity and mild conditions for pharmaceutical manufacturing.
Patent CN113735867B reveals mild synthesis for antitumor intermediates. Offers high yield and enantioselectivity for cost-effective supply chain solutions.
Patent CN111848322B details a novel chiral phosphoric acid catalyzed resolution for axially chiral oxindole styrenes, offering high enantioselectivity and mild conditions for pharmaceutical intermediates.
Patent CN112209947A details a mild, high-yield synthesis of chiral indoxazinones with potent anti-tumor activity, offering reliable supply chain solutions.
Novel chiral phosphoric acid catalyzed synthesis of indoxazinones with high enantioselectivity and mild conditions for anticancer drug development.
Patent CN118878452B reveals a mild catalytic route for anti-tumor intermediates. This report analyzes supply chain stability and cost reduction in pharma manufacturing.
Patent CN114920775B reveals high-selectivity catalyst synthesis. Offers cost reduction in pharmaceutical manufacturing and reliable supply chain solutions.
Novel synthesis method offers mild conditions and high yield for pharmaceutical intermediates ensuring cost reduction and supply chain reliability for global partners seeking advanced antitumor solutions
Novel synthesis method for chiral indolo compounds with high enantioselectivity. Cost-effective manufacturing for pharmaceutical applications ensuring supply chain reliability.
Patent CN120923511A details mild synthesis of chiral vinyl indolo compounds. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN111217693A details a cuprous halide catalyzed carboxylation method using CO2, offering cost-effective routes for high-purity pharmaceutical intermediates and fine chemicals.
Patent CN110467555A reveals mild chiral phosphoric acid catalysis for high-purity pharmaceutical intermediates. Enables cost reduction and supply chain reliability for global buyers.
Novel isoindolone-based antitumor compound synthesis via patent CN119874717B. Mild conditions, high yield. Reliable pharmaceutical intermediate supplier for scale-up.
Patent CN111217847B introduces efficient thiosilane ligands for aryl boronation, offering high yield and purity for reliable pharmaceutical intermediate supply chains.
Patent CN115385916B details a novel chiral phosphoric acid catalyzed route offering high enantioselectivity and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN110452150B details a mild, one-step synthesis of axial chiral indole-naphthalenes with high enantioselectivity, offering cost-effective solutions for chiral catalyst manufacturing.